H2020
PHAGO
Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976
- Programme
- Horizon 2020
- Started
- Ends
- Duration
- 66 months
- Total cost
- EUR 18,221,231
- EU contribution
- EUR 8,838,000
- Participants
- 19 from 8 countries
- Topic
- H2020_IMI2-2015-05-03
- Grant agreement
- 115976
Coordinated by Universitatsklinikum Bonn (DEGermany).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Universitatsklinikum Bonn | DEGermany | Coordinator | EUR 1,754,200 | known name (0.95) |
| Janssen Pharmaceutica NV | BEBelgium | Participant | EUR 0 | PIC (1.00) |
| Abbvie Deutschland GmbH & Co KG | DEGermany | Participant | EUR 0 | PIC (1.00) |
| Arttic Innovation GmbH | DEGermany | Third party | Not stated | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 538,750 | PIC (1.00) |
| Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev | DEGermany | Participant | EUR 1,027,500 | known name (0.97) |
| Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschung Ev | DEGermany | Participant | EUR 500,000 | known name (0.95) |
| Life and Brain GmbH | DEGermany | Participant | EUR 451,250 | PIC (1.00) |
| H. Lundbeck As | DKDenmark | Participant | EUR 0 | PIC (1.00) |
| Orion OYJ | FIFinland | Participant | EUR 0 | PIC (1.00) |
| Sanofi-Aventis Recherche & Developpement | FRFrance | Participant | EUR 0 | PIC (1.00) |
| Eisai Limited | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| Eli Lilly and Company Ltd | GBUnited Kingdom | Participant | EUR 0 | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 1,115,000 | known name (0.95) |
| The Chancellor Masters and Scholars of the University of Cambridge | GBUnited Kingdom | Participant | EUR 1,052,500 | known name (0.95) |
| University College London | GBUnited Kingdom | Participant | EUR 994,144 | known name (0.95) |
| Axxam SpA | ITItaly | Participant | EUR 438,750 | PIC (1.00) |
| Astrazeneca AB | SESweden | Participant | EUR 0 | PIC (1.00) |
| Goeteborgs Universitet | SESweden | Participant | EUR 372,156 | PIC (1.00) |
Changes of the consortium
First seen on with 19 participants from 8 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.